Leafly Holdings, Inc. (LFLY)
USD 1.35
(4.65%)
USD 1.35
(4.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.74 USD | -121.79% |
| 2022 | 21.75 USD | 303.08% |
| 2021 | -10.71 USD | 17.04% |
| 2020 | -12.91 USD | 67.08% |
| 2019 | -39.22 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.55 USD | 49.54% |
| 2024 Q1 | -1.09 USD | -395.45% |
| 2023 Q1 | -3.39 USD | 0.29% |
| 2023 FY | - USD | -121.79% |
| 2023 Q3 | -1.10 USD | -50.68% |
| 2023 Q2 | -0.73 USD | 78.47% |
| 2023 Q4 | -0.22 USD | 80.0% |
| 2022 Q1 | -16.69 USD | -570.28% |
| 2022 Q4 | -3.40 USD | -139.13% |
| 2022 Q3 | 8.69 USD | -52.41% |
| 2022 FY | - USD | 303.08% |
| 2022 Q2 | 18.26 USD | 209.41% |
| 2021 FY | - USD | 17.04% |
| 2021 Q4 | -2.49 USD | -15.28% |
| 2021 Q3 | -2.16 USD | -237.5% |
| 2021 Q2 | -0.64 USD | -18.52% |
| 2021 Q1 | -0.54 USD | -12.5% |
| 2020 Q4 | -0.48 USD | -2023.89% |
| 2020 Q3 | -0.02 USD | 12.74% |
| 2020 Q1 | 0.10 USD | 0.0% |
| 2020 Q2 | -0.03 USD | -126.29% |
| 2020 FY | - USD | 67.08% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -52.60 USD | 90.989% |
| BIMI International Medical Inc. | -8.40 USD | 43.571% |
| China Jo-Jo Drugstores, Inc. | -2.93 USD | -61.775% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -0.75 USD | -532.0% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -0.75 USD | -532.0% |
| Leafly Holdings, Inc. | -4.74 USD | -0.0% |
| LifeMD, Inc. | -0.70 USD | -577.143% |
| LifeMD, Inc. | -0.70 USD | -577.143% |
| TRxADE HEALTH, Inc. | -23.35 USD | 79.7% |
| PetMed Express, Inc. | -0.37 USD | -1181.081% |
| Walgreens Boots Alliance, Inc. | -10.01 USD | 52.647% |